Todd Mittleman, M.A. leads the development of NGL’s pipeline of advanced diagnostic tests across the product life-cycle from concept to market launch. Previous to NextGen Labs, Todd was with the Mind Research Network (MRN) where, as Business Development Director, he leveraged MRN’s capabilities in neuroimaging, genetics and bioinformatics to secure funding from biotech and government agencies for drug development and point-of-care neurotechnology applications. He brings with him over 15 years of experience working with R&D and clinical research teams to bring advanced and personalized medicine and genetic testing technologies to market, and is leading the current expansion into next generation sequencing (NGS) and rapid infectious disease diagnostic tests capable of identifying antibiotic resistance markers in both common and rare infections. Projects in development include expanding NGL’s bioinformatics capabilities, NGS oncology testing, and continuing to develop programs in education and training for sales teams and clinicians.